Connect with us

Business

Protara Therapeutics, Inc. (TARA) Discusses Updated Interim Results for TARA-002 in Phase II ADVANCE-2 Trial for BCG-Naive NMIBC Patients - Slideshow
Advertisement

Business

Kaynes shares plunge 43% from October peak. Is a tactical rebound on the cards or more pain ahead?

Business

Microsoft: Path To $600

Business

Constellation Energy: AI Makes Nuclear Power A Profit Magnet

Business

Brown-Forman: Not Out Of The Woods, Yet - Dividend Still In Danger

Business

Nifty at 26K, but why is your stock portfolio bleeding?

Business

Bullish Case Or Bearish Backdrop

Business

Warren Buffett is buying, Michael Burry is shorting: The AI trade splitting Wall Street

Business

Hims & Hers: The Market's Panic Is Irrational (NYSE:HIMS)

Business

Why Netflix Shareholders Aren’t Thrilled to Acquire Warner Bros.

Business

Enovix: Are The Commons A Buy After The Dip?

Business

The Bond Of Atlanticus Holdings Is Offering A 9.1% Yield To Maturity

Business

Lands’ End: Mixed Fundamentals And Declining FCF Suggests A Hold (NASDAQ:LE)

Business

Week Ahead: Fed To Cut But RBA, SNB, And Bank Of Canada Set To Hold, And Market Thinks They Are Done

Business

CLOI: Low Potential For Revaluation

Business

FinVolution: Cheap, Consistent, And Expanding Abroad

Business

AI Stocks Are a Bet on the Future. Markets Are Ignoring the Now.

Business

PWB: Growth Is Now More Appealing (NYSEARCA:PWB)

Business

WPAY Vs. YMAX: Don't Let The 69% Yield Fool You (BATS:WPAY)

Business

Why Home Buyers See Some Hope in 2026

Business

S&P 500 Snapshot: Win Streak Puts Index Inches From Record High

Business

Redcar Area Foodbank running reverse advent calendar

Business

Carvana, Comfort Systems, CRH To Join S&P 500 Index. The Stocks Are Jumping.

Business

Chewy: Priced For Perfection While Competition Heats Up

Business

One Man’s Mission to Get Back $4 Million of Stolen Skincare Products

Business

ORIC Pharmaceuticals, Inc. (ORIC) Discusses Enozertinib Phase Ib Results and Differentiation in EGFR-Mutated Non-Small Cell Lung Cancer Transcript

Business

Apple Stock Can Rise on Services Segment, Says Analyst. Plus, Uber, American Eagle, and More.

Business

Cenovus Energy: Buying Scale, Boosting Returns, And Still Undervalued (NYSE:CVE)

Business

Ashland, Bitdeer, and More Stocks See Action From Activist Investors

Business

Spotify: The Network Economy In The Audio Industry

Business

Mcap of five of top-10 most-valued firms surges Rs 72,285 cr; TCS, Infosys biggest winners

Business

TSMC: Unmatched Moat, Secular AI Tailwinds, And Still A Buy At Highs

Business

The Score: Warner, Boeing, Dollar General, American Eagle and More Stocks That Defined the Week

Business

SoftBank-backed AceVector files updated IPO papers; targets to raise Rs 300 cr via fresh issue

Business

Markets Weekly Outlook - FOMC Rate Cut Countdown, Economic Projections May Hold The Key

Business

Warner Discovery Market Cap Jumps to Record

Business

New Management Has Definitely Shifted The Tone At 3M, But Follow-Through On Growth Is Essential

Business

Heard on the Street Recap: Streaming Wars Go Nuclear

Business

Investors Look Ahead to Rate Cuts, Lifting Stocks Near Records

Business

Wall Street bets Chinese stocks will extend $2.4 trillion rally

Business

Protara Therapeutics, Inc. (TARA) Discusses Updated Interim Results for TARA-002 in Phase II ADVANCE-2 Trial for BCG-Naive NMIBC Patients – Slideshow

Published

3 days ago

on

Else Nutrition Holdings Inc. (BABY:CA) Q3 2025 Earnings Call Transcript

Protara Therapeutics, Inc. (TARA) Discusses Updated Interim Results for TARA-002 in Phase II ADVANCE-2 Trial for BCG-Naive NMIBC Patients – Slideshow

Source link

Related Topics:
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2025 Wordupnews.com